A study by U.S. and Egyptian researchers has challenged the conventional wisdom regarding cardiovascular disease.
A study by U.S. and Egyptian researchers has challenged the conventional wisdom regarding cardiovascular disease. Using CT, the investigators found evidence that, unlike other chronic conditions that plague affluent postindustrial Western societies, atherosclerosis has been around since at least the time of the ancient pharaohs.
“Some of the patients I have mentioned the study to have had a certain sense of relief,” lead investigator Dr. Randall Thompson told Diagnostic Imaging. “They were blaming themselves for having had a heart attack and were happy to learn that the disease has been around since the time of Moses.”
Thompson and colleagues sought evidence of arterial disease in individuals who lived three millennia or longer ago. They performed whole-body multislice CT scans on 22 mummies preserved in the Egyptian National Museum of Antiquities in Cairo. The investigators found evidence of atherosclerosis of the abdominal or thoracic aorta or peripheral arteries in nine of 16 mummies with visible cardiovascular tissue. This included seven subjects who were 45 or older and two who were younger than 45 when they died. Findings appeared in the Nov. 18 issue of the Journal of the American Medical Association.
The study lacks a direct pathological correlation and the power to explain the prevalence or severity of atherosclerosis in the distant past. However, it does provide proof that ancient Egyptians belonging to the upper social strata who were middle-aged or older already faced a genetic and environmental predisposition to develop the condition, said Thompson, a cardiologist at St. Luke's Hospital's Mid America Heart Institute in Kansas City, MO.
“The findings challenge the concept that this is primarily a disease of Western lifestyles,” he said.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.